These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28406855)

  • 1. Beyond the Treatment Box: Perspectives on the Federal Response to Opioid Use, Pregnancy, and Neonatal Abstinence Syndrome.
    Terplan M
    J Addict Med; 2017; 11(3):176-177. PubMed ID: 28406855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal Opioid Withdrawal Syndrome.
    Patrick SW; Barfield WD; Poindexter BB;
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33106341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.
    Kroelinger CD; Rice ME; Cox S; Hickner HR; Weber MK; Romero L; Ko JY; Addison D; Mueller T; Shapiro-Mendoza C; Fehrenbach SN; Honein MA; Barfield WD
    MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(36):777-783. PubMed ID: 31513558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid Exposed Mothers and Infants in Delaware: Clinical and Legal Considerations.
    Savin MK; Paul DA
    Del Med J; 2016 Apr; 88(4):110-4. PubMed ID: 27263243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.
    Krans EE; Patrick SW
    Obstet Gynecol; 2016 Jul; 128(1):4-10. PubMed ID: 27275812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges.
    Saunders JB; Jarlenski MP; Levy R; Kozhimannil KB
    Womens Health Issues; 2018; 28(2):130-136. PubMed ID: 29183818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of Tennessee's Opioid Legislation for Neonatal Abstinence Syndrome.
    Shearer JN; Erwin PC; Davis SK; Anderson JG; Lindley LC
    Policy Polit Nurs Pract; 2019 Aug; 20(3):153-162. PubMed ID: 31390304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal Abstinence Syndrome In The United States, 2004-16.
    Leech AA; Cooper WO; McNeer E; Scott TA; Patrick SW
    Health Aff (Millwood); 2020 May; 39(5):764-767. PubMed ID: 32364857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revision of Breastfeeding Guidelines in the Setting of Maternal Opioid Use Disorder: One Institution's Experience.
    Wachman EM; Saia K; Humphreys R; Minear S; Combs G; Philipp BL
    J Hum Lact; 2016 May; 32(2):382-7. PubMed ID: 26514156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.
    Pryor JR; Maalouf FI; Krans EE; Schumacher RE; Cooper WO; Patrick SW
    Arch Dis Child Fetal Neonatal Ed; 2017 Mar; 102(2):F183-F187. PubMed ID: 28073819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
    Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
    Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome.
    Wolf ER; Tong ST; Sabo RT; Woolf SH; Abbinanti K; Pecsok J; Krist AH
    BMC Pediatr; 2019 Oct; 19(1):371. PubMed ID: 31640614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing a Learning Collaborative Framework for States Working to Improve Outcomes for Vulnerable Populations: The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community.
    Kroelinger CD; Addison D; Rodriguez M; Rice ME; Frey MT; Hickner HR; Weber MK; Mueller T; Velonis A; Uesugi K; Romero L; Akbarali S; Foster N; Ko JY; Pliska E; Mackie C; Cox S; Fehrenbach SN; Barfield WD
    J Womens Health (Larchmt); 2020 Apr; 29(4):475-486. PubMed ID: 32176568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-centered Care to Address Barriers for Pregnant Women with Opioid Dependence.
    Sutter MB; Gopman S; Leeman L
    Obstet Gynecol Clin North Am; 2017 Mar; 44(1):95-107. PubMed ID: 28160896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitioning Care Approach for Neonatal Opioid Withdrawal Syndrome and Neonatal Abstinence Syndrome.
    Perez C
    Crit Care Nurs Clin North Am; 2024 Jun; 36(2):223-233. PubMed ID: 38705690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal Abstinence Syndrome.
    Jansson LM; Patrick SW
    Pediatr Clin North Am; 2019 Apr; 66(2):353-367. PubMed ID: 30819342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid Use and Abuse and Neonatal Abstinence Syndrome.
    DeVane CL
    Pharmacotherapy; 2017 Jul; 37(7):779-780. PubMed ID: 28726245
    [No Abstract]   [Full Text] [Related]  

  • 19. Opioid Use Disorders and Pregnancy.
    Johnson AJ; Jones CW
    Obstet Gynecol Clin North Am; 2018 Jun; 45(2):201-216. PubMed ID: 29747726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetric management of women with opioid use disorder.
    Rosenthal EW; Baxter JK
    Semin Perinatol; 2019 Apr; 43(3):168-172. PubMed ID: 30711196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.